HOME  |  CONTACT US  |  SUBSCRIBE  |  SUPPORT WLF

Publication Detail


First Circuit Breathes New Life into Branded Drug Preemption Defense
Topic: Health Care
Andrew T. Bayman and Todd P. Davis are partners in the Atlanta office of the law firm King & Spalding LLP. Mark S. Brown and Jeffrey S. Bucholtz are partners in the firmís Washington, D.C. office.
Counsel's Advisory, March 27, 2015, 1 pages
Download a PDF of the Publication
Publication Summary:

PUBLICATION SUMMARY

Creative arguments by branded pharmaceutical companies in state-law failure-to-warn legal actions have led to new opportunities to argue federal preemption, as reflected in a recent U.S. Court of Appeals for the First Circuit decision.
  • Welcome to the Washington Legal Foundation
  • 2009 Massachusetts Ave., NW
    Washington, DC 20036
  • info@wlf.org  |  ph. 202-588-0302
    ©2017 WLF All Rights Reserved